damnacanthal has been researched along with Liver Neoplasms in 1 studies
damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity
Liver Neoplasms: Tumors or cancer of the LIVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Vilas, JA | 1 |
| Quesada, AR | 1 |
| Medina, MA | 1 |
1 other study available for damnacanthal and Liver Neoplasms
| Article | Year |
|---|---|
Damnacanthal, a noni anthraquinone, inhibits c-Met and is a potent antitumor compound against Hep G2 human hepatocellular carcinoma cells.
Topics: Anthraquinones; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Gene Expression Regulation | 2015 |